These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20274525)

  • 1. Pharmacological and chemotherapeutic properties of 3,4-dimethyl-5-sulfanilamido-isoxazole.
    SCHNITZER RJ; FOSTER RH
    J Pharmacol Exp Ther; 1946 Sep; 88(1):47-57. PubMed ID: 20274525
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative merits of 3, 4-dimethyl-5-sulfanilamido-isoxazole (gantrisin) and a sulfapyrimidine triple mixture; an evaluation of properties important at the bedside.
    LEHR D
    Antibiot Chemother (Northfield); 1953 Jan; 3(1):71-93. PubMed ID: 24542282
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on 3,4-dimethyl-5-sulfanilamido-isoxazole (Nu-445) in humans.
    SARNOFF SJ
    Proc Soc Exp Biol Med; 1948 May; 68(1):23-6. PubMed ID: 18863664
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative experimental studies on 5-methyl-3-sulfanilamido-isoxazole, other sulfanilamides and antibiotics].
    FUST B; BOEHNI E
    Schweiz Med Wochenschr; 1962 Dec; 92():1599-604. PubMed ID: 13945938
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early results of 3,4-dimethyl-5-sulfanilamido-isoxazole therapy of acute and chronic infections of the lung].
    ANNEDDA L; ROMAGNANI L
    Gazz Med Ital; 1953 May; 112(5):146-9. PubMed ID: 13083873
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of pneumonia and other infections with a soluble sulfonamide, gantrosan (NU-445; 3,4-dimethyl-5-sulfanilamido-isoxazole).
    BRICKHOUSE RL; LEPPER MH
    Am J Med Sci; 1949 Aug; 218(2):133-7. PubMed ID: 18135998
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with the new sulfonamide 5-methyl-3-sulfanilamido-isoxazole].
    HOCHULI E
    Schweiz Med Wochenschr; 1962 Dec; 92():1604-7. PubMed ID: 13963750
    [No Abstract]   [Full Text] [Related]  

  • 8. The experimental pharmacology and effectiveness of 3-4, dimethyl-5-sulfanilamide-isoxazole.
    BRYER MS; SCHOENBACH EB
    Bull Johns Hopkins Hosp; 1948 Jun; 82(6):633-5. PubMed ID: 18856850
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between cholinesterase inhibition and the pharmacological action of di-isopropyl fluorophosphate (DFP).
    KOELLE GB; GILMAN A
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):421-34. PubMed ID: 20279263
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of a new sulfonamide preparation: Gantrisin by Roche: 3,4-Dimethyl-5-sulfanilamido-isoxazol].
    LANGEMANN H
    Schweiz Med Wochenschr; 1950 Jan; 80(4):78-81. PubMed ID: 15404422
    [No Abstract]   [Full Text] [Related]  

  • 11. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole].
    WOERFFEL U; BEHNISCH R
    Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov; 295/67():811-6. PubMed ID: 14001457
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of di-isopropyl fluorophosphate on normal human eyes.
    SCHOLZ RO; WALLEN LJ
    J Pharmacol Exp Ther; 1946 Nov; 88(3):238-45. PubMed ID: 20274547
    [No Abstract]   [Full Text] [Related]  

  • 13. The acute toxicity of di-isopropyl fluorophosphate.
    HORTON RG; KOELLE GB
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):414-20. PubMed ID: 20279262
    [No Abstract]   [Full Text] [Related]  

  • 14. Antidotes to poisoning by di-isopropyl fluorophosphate in cats.
    MODELL W; KROP S
    J Pharmacol Exp Ther; 1946 Sep; 88(1):34-8. PubMed ID: 20274523
    [No Abstract]   [Full Text] [Related]  

  • 15. [New sulfur preparation. On treatment with 4,5-dimethyl-1-2-sulfanilamido-oxazole (Sulfumol)].
    BRANDBERG O; WESSNER G
    Sven Lakartidn; 1962 Mar; 59():995-1000. PubMed ID: 13872472
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of di-isopropyl fluorophosphate (DFP) poisoning in rabbits.
    McNAMARA BP; KOELLE GB; GILMAN A
    J Pharmacol Exp Ther; 1946 Sep; 88(1):27-33. PubMed ID: 20274522
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the ocular reactions of rabbits to di-isopropyl fluorophosphate.
    SCHOLZ RO
    J Pharmacol Exp Ther; 1946 Sep; 88(1):23-6. PubMed ID: 20274521
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergisms and antagonisms between physostigmine and di-isopropyl fluorophosphate in cats.
    KOSTER R
    J Pharmacol Exp Ther; 1946 Sep; 88(1):39-46. PubMed ID: 20274524
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection of cholinesterase against irreversible inactivation by di-isopropyl fluorophosphate in vitro.
    KOELLE GB
    J Pharmacol Exp Ther; 1946 Nov; 88(3):232-7. PubMed ID: 20274546
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologically active nuclear-substituted sulfonamides. I. Chemical and physical properties of some nuclear-substituted sulfanilamido-2-thiazoles and their syntheses.
    QUAN SF; DANIELS TC; KUMLER WD
    J Am Pharm Assoc Am Pharm Assoc; 1954 Jun; 43(6 1):321-6. PubMed ID: 13174427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.